BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27595689)

  • 21. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133
    Steinhoff G; Nesteruk J; Wolfien M; Kundt G; ; Börgermann J; David R; Garbade J; Große J; Haverich A; Hennig H; Kaminski A; Lotz J; Mohr FW; Müller P; Oostendorp R; Ruch U; Sarikouch S; Skorska A; Stamm C; Tiedemann G; Wagner FM; Wolkenhauer O
    EBioMedicine; 2017 Aug; 22():208-224. PubMed ID: 28781130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximizing ventricular function with multimodal cell-based gene therapy.
    Yau TM; Kim C; Li G; Zhang Y; Weisel RD; Li RK
    Circulation; 2005 Aug; 112(9 Suppl):I123-8. PubMed ID: 16159803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.
    Limsuwan A; Pienvichit P; Limpijankit T; Khowsathit P; Hongeng S; Pornkul R; Siripornpitak S; Boonbaichaiyapruk S
    Clin Cardiol; 2010 Aug; 33(8):E7-12. PubMed ID: 20632394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. eNOS overexpressing bone marrow cells are safe and effective in a porcine model of myocardial regeneration following acute myocardial infarction.
    Ward MR; Connelly KA; Vijayaraghavan R; Vaags AK; Graham JJ; Foltz W; Hough MR; Stewart DJ; Dick A
    Cardiovasc Ther; 2013 Dec; 31(6):e72-8. PubMed ID: 23837864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.
    Quijada P; Toko H; Fischer KM; Bailey B; Reilly P; Hunt KD; Gude NA; Avitabile D; Sussman MA
    Circ Res; 2012 Jun; 111(1):77-86. PubMed ID: 22619278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial.
    Schaefer A; Meyer GP; Fuchs M; Klein G; Kaplan M; Wollert KC; Drexler H
    Eur Heart J; 2006 Apr; 27(8):929-35. PubMed ID: 16510465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained-release delivery of prostacyclin analogue enhances bone marrow-cell recruitment and yields functional benefits for acute myocardial infarction in mice.
    Imanishi Y; Miyagawa S; Fukushima S; Ishimaru K; Sougawa N; Saito A; Sakai Y; Sawa Y
    PLoS One; 2013; 8(7):e69302. PubMed ID: 23894446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
    Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging impairs human bone marrow function and cardiac repair following myocardial infarction in a humanized chimeric mouse.
    Marvasti TB; Alibhai FJ; Wlodarek L; Fu A; Li SH; Wu J; Weisel RD; Cusimano RJ; Ouzounian M; Yau T; Li RK
    Aging Cell; 2021 Nov; 20(11):e13494. PubMed ID: 34612564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
    Musialek P; Tekieli L; Kostkiewicz M; Miszalski-Jamka T; Klimeczek P; Mazur W; Szot W; Majka M; Banys RP; Jarocha D; Walter Z; Krupinski M; Pieniazek P; Olszowska M; Zmudka K; Pasowicz M; Kereiakes DJ; Tracz W; Podolec P; Wojakowski W
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):320-8. PubMed ID: 23271789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
    Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
    Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
    Perin EC; Willerson JT; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Silva GV; Lai D; Thomas JD; Kronenberg MW; Martin AD; Anderson RD; Traverse JH; Penn MS; Anwaruddin S; Hatzopoulos AK; Gee AP; Taylor DA; Cogle CR; Smith D; Westbrook L; Chen J; Handberg E; Olson RE; Geither C; Bowman S; Francescon J; Baraniuk S; Piller LB; Simpson LM; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Apr; 307(16):1717-26. PubMed ID: 22447880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does mobilisation of CD34+ stem cells along with VEGF, angiogenin, IL-6, IL-8, and hsCRP levels allow predicting the direction of left ventricular ejection fraction and wall motion score index changes in patients with myocardial infarction?
    Grąbczewska Z; Dębski R; Góralczyk K; Świątkiewicz I; Kubica J
    Kardiol Pol; 2013; 71(5):464-71. PubMed ID: 23788086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of bone marrow cell homing into the infarcted human myocardium.
    Hofmann M; Wollert KC; Meyer GP; Menke A; Arseniev L; Hertenstein B; Ganser A; Knapp WH; Drexler H
    Circulation; 2005 May; 111(17):2198-202. PubMed ID: 15851598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.